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Introduction
Crohn's disease (CD) and ulcerative colitis (UC) are two
main disease entities of a group of idiopathic
inflammatory intestinal conditions that collectively
constitute inflammatory bowel disease (IBD). Both
conditions have overlapping and distinct clinical and
pathological features, but pathogenesis is incompletely
understood. Genetic and environmental factors are
postulated to cause dysregulation of intestinal immunity,
leading to gastrointestinal injury.1
There is paucity of valid epidemiological studies on IBD
from Asian countries and the results are variable. The
incidence of UC ranged from 1.0 to 2.0 per 100000
person-years. The incidence of CD ranges from 0.5 to 1.0
per 100000 person-years. The prevalence of UC has
ranged from 4.0 to 44.3per 100000 and that of CD from
3.6 to 7.7 per 100000. UC appears to be more common
than CD in Asia. There is no epidemiological study from
Pakistan.
IBD is a chronic, intermittent disease. In general,
symptoms depend on the segment of the intestinal tract
involved. It can present with cramp-like abdominal pain,
bloody diarrhoea, and tenesmus. Some cases may present
with a fulminant course marked by severe diarrhoea,
fever, leucocytosis, and abdominal distension associated
with various extra-colonic manifestations.
Therapy for IBD is a rapidly evolving field, with many new
biologicala gents under investigation. Currently used
drugs are amino salicylates, corticosteroids, thiopurines,
methotrexate and infliximab.2-4 Currently there is no cure
for CD; therapy is directed at achieving and maintaining
remission, and to achieve optimum quality of life. The
approach is similar with UC, although UC technically can
be "cured" by surgical removal of the large intestine.
Surgery is generally reserved for patients with
intractability, colorectal cancer, toxic megacolon, massive
bleeding or perforation.
IBD renders patients at risk of several complications,
including colorectal cancer (CRC). It is believed that this
increased risk is a result of persistent inflammation of the
colon. Risk factors for the development of CRC in the
setting of IBD include disease duration, anatomic extent
of disease, age at time of diagnosis, severity of
inflammation, family history of colon cancer, and
concomitant primary sclerosing cholangitis.5
There is limited data available from Pakistan regarding
surgical management of this important clinical condition.
The current study was planned to determine the
outcomes of surgical management of IBD at a tertiary care
teaching hospital of Pakistan.
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Abstract
Objective: To determine the outcomes of surgical management of inflammatory bowel disease.
Methods: The retrospective case series was conducted at Aga Khan University Hospital, Karachi, and comprised
medical record of adult patients operated between January 1986 and December 2010 for inflammatory bowel
disease. Outcomes consisted of complications till last follow-up and 30-day mortality (disease or procedure related).
Functional status of patients with ileal pouch was determined via telephone. SPSS 16 was used to analyse data.
Results: Of the 36 patients whose records were reviewed, 21(58%) were males, and body mass index was less than
23 in 34(91%). A total of 27(75%) patients underwent elective surgery for their condition. Ileal pouch was formed in
9(25%). Overall mortality was 14(38.8%). Overall incidence of complications was 26(72%), with wound infection
being the most common early morbidity in 11(30.5%). Late morbidity included pouchitisin 4/9 (44.9%) and
strictures 2/36 (5.5%).On telephonic follow-up, 6 of the remaining 7patients (85%) with ileal pouch were satisfied
with the functional results of the procedure.
Conclusion: The retrospective case series represents results from a developing country with low prevalence of
inflammatory bowel disease and hence limited experience.
Keywords: Inflammatory bowel disease, Morbidity, Mortality, Ileal pouch, Anal anastamosis. (JPMA 66: 247; 2016)
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Patients and Methods
The retrospective case series was conducted at Aga Khan
University Hospital (AKUH), Karachi, and comprised
medical record of adult patients operated between
January 1986 and December 2010 for IBD. International
Classification of Diseases (ICD) code for IBD was run to
retrieve the charts of patients. Patients with missing
records and surgery done outside AKUH were excluded.
The charts were reviewed by a General Surgery Resident
for socio-demographic, surgical and outcome variables.
Since these patients are followed regularly and for long
term, their records are not purged as per institutional
policy. Outcomes consisted of complications till last
follow-up and 30-day mortality either disease or
procedure-related. Patients with ileal pouch were
contacted via telephone (since this procedure was
performed in recent years) to inquire whether or not they
were satisfied with the functional outcome. Satisfaction
was defined as frequency of stools less than four per day
and good continence.
SPSS 16 was used to analyse the data. Descriptive analysis
of baseline characteristics was done. Categorical variables
like gender, comorbids and outcomes were analysed as
proportions. Continuous variables like age, body mass
index (BMI) and duration of surgery were analysed as
means ±standard deviation.
Results
A total of 47 patients underwent surgical treatment for
IBD during the study period, records of 36(76.5%) were
included after leaving out 11(23.4%) with missing
data/files. There were 21(58%) males; BMI was less than 23
in 34(91%); 10(28%) patients were operated for CD and
26(72%) for UC (Table).
The most commonly reported symptom at
the time of presentation was abdominal
pain in 28(77.7%) patients, followed by
diarrhoea 25(69%) and haematochezia
23((64%). Additionally, patients commonly
presented with constitutional symptoms
such as fatigue in 18(50%), fever 13(36.1%),
weight loss 13(36.1%) and loss of appetite
11(30.5%). Associated conditions were
anaemia in 18(50%), anxiety 5(13.8%) and
depression 5(13.8%). The mean duration of
symptoms prior to diagnosis was 5±4.3
years, whereas after diagnosis it was 7.5±3.6
years. CRC was diagnosed in 15(41.6%)
patients, and 14(93.3%) of them had UC.
Medical treatment consisted of
sulfonamides in 7(19.4%), aminosalicylates 16(44.4%) and
immunosuppressive therapy using prednisone 15(41.6%)
or prednisone in combination with another
immunosuppressive drug 6(16.6%).
A total of 27(75%) patients underwent elective surgery for
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MOF: Major osteoporotic fractures
UTI: Urinary tract infection.
Figure: Early post-operative complications (n=36).
Table: Socio-demographic and clinical characteristics of patients (n=36).
Variable Values
Age (years) 45±15
Body mass index (BMI) 22.2±5.8
<19 18 (49%)
19.1-23 16 (42%)
>23.1 02 (9%)
Gender 58% (21)
Comorbids
Diabetes mellitus (DM) 19.4% (7)
Hypertension (HTN) 25% (9)
Asthma 8.2% (3)
Colorectal Cancer 15 (41.6%)
Incidental diagnosis 1
Preoperative diagnosis 14
Indication for surgery
Bleeding 2 (5.5%)
Perforation 4 (11%)
Obstruction 5 (13.8%)
Tumor 3 (8.2%)
Intractability 14 (38.8%)
Others 10 (27.6%)
Emergency surgery 9 (25%)
Surgical procedure
Ileal-pouch Anal Anastamosis 09 (25%)
Total colectomy+ileostomy 13 (36%)
Segmental Resection+ileostomy 03 (08%)
Segmental Resection+anastamosis 11 (31%)
their condition and 9(25%) underwent emergency
surgery. Most common procedure was total colectomy
with ileostomy 11 (36%) followed by segmental resection
and ileostomy 13 (31%). Ileal pouch was formed in 9(25%)
patients.
Overall mortality was 14(38.8%); 8(57%)expired during
post-operative hospital course, and 6(43%)expired within
30 days of surgery after being discharged from hospital.
Four (28.5%) patients expired within one week of
emergency surgery (perforation, megacolon or massive
bleeding) and were American Society of Anesthesiologists
(ASA) grade III or IV. Overall incidence of complications was
26(72%) (Figure) and wound infection in 11(30.5%) was
the most common cause of early morbidity. Late morbidity
included pouchitis in 4/9(44.4%) and strictures in
2/36(5.5%). Mean hospital stay was 16 days. Two (22.2%)
out of 9 patients with ileal pouch expired within two weeks
of surgery due to multiorgan failure secondary to
septicaemia. On telephonic follow-up, 6(85%) of seven
patients who survived an ileal pouch were satisfied with
the functional results of the procedure.
Discussion
This retrospective case series represent results from a
tertiary care centre of developing country with low
prevalence of IBD. Most patients underwent resection and
anastamosis (or ileostomy); while 25% underwent ileal
pouch-anal anastomosis (IPAA). Overall morbidity and
mortality was 72% and 38.8%, respectively, which is much
higher than internationally reported data. One study
reported a morbidity of upto 50%,6 most common of all
complications was pouchitis (50%) followed by intestinal
obstruction (25%). Another study considered total
abdominal colectomy with end ileostomy a safe
procedure in the emergent setting with a post-operative
complication rate of 23%-33% and low mortality in the
absence of a perforation (0%-4%).7 As far as IPAA is
concerned, it's a low-mortality procedure (upto 1%);
however, the morbidity is considerable i.e. upto 50%.7
High morbidity and mortality in our study may be
attributed to small sample size, limited experience of
managing such cases requiring multidisciplinary
approach, immunosuppression due to drugs and
malnutrition.
The incidence of UC has been increasing in previously
low-incidence areas i.e. eastern Europe, Asia, and
developing countries, including Pakistan. There are other
socio-demographic differences between east and west;
extra-intestinal disease reported from Pakistan is less than
that reported from the West. Fistulisation is less common
in India and Pakistan, and the age at presentation of CD is
a decade later in India than in the West.1
Approximately 25%-35% of UC patients ultimately require
surgery for either a complication of the disease or
inadequate control of symptoms.3 While most of these
surgeries can be done in the setting of an elective
operation, a minority will require urgent treatment.
Indications for emergent operation for UC include
massive haemorrhage, toxic colitis, toxic mega-colon, and
intestinal perforation. Total abdominal colectomy and
end ileostomy is the procedure of choice in emergency
settings,8 whereas most frequent elective procedure
performed for UC is the restorative proctocolectomy with
IPAA.9
It is estimated that between 70% and 90% of Crohn's
patients will need a surgical intervention at some point
during their disease.10 Operative intervention for CD is
indicated when medical therapies fail to adequately
alleviate symptoms, or when patients develop one of
several complications of the disease; specifically, these
include fistula, abscess, obstruction and malnutrition.
Persistent symptoms that compromise quality of life
despite several months of aggressive medical
management, or recurrent symptoms following repeated
attempts to taper aggressive therapies, are well-described
indications for surgery. Adverse reactions to medical
therapies, most often steroids, sometimes prompt a more
aggressive surgical approach to the control of CD
symptoms as well.11
Resection is the most commonly performed surgical
procedure for small bowel CD.12 In general, the pan-enteric
nature of CD has resulted in a surgical philosophy of
conservatism. Recurrence rates tend to increase with the
passage of time and CD patients may eventually require
multiple resections, each increasing the risk of short-bowel
syndrome and its associated metabolic morbidities.
Recurrence rates following resection remain high.
IBD patients need to be hospitalised either for surgery or
for refractory disease and hospitalisation accounts for at
least half of the direct costs attributable to IBD. About
70%-75% of CD patients require surgery for symptomatic
relief; surgery is rarely curative. Contrarily, 25%-30% of
UC patients may require surgery, and surgery is
considered curative for the disease. About 30% of those
with total colitis require colectomy within 5 years.1 This
trend can also be observed in our study and out of 36
patients managed surgically, 26(72%) had UC and
10(28%) had CD. Most common indication in our setup
was resistant medical therapy, which was found in
14(38.8%) patients followed by tumour (21%). Out of 36
surgeries performed, 9(25%) were emergency surgeries;
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seven UC patients and 2 of CD.
In a retrospective review13 of 173 patients who
underwent total proctocolectomy with IPAA, median
functional O¨ resland score 1 year after IPAA was 3 (range
0-11). Early postoperative complications were observed in
27% patients. After a median (interquartile range) follow-
up of 6.5 (3.4 -9.9) years, 35% patients developed septic
and/or obstructive complications and 46% patients had at
least one episode of pouchitis. Pouch failure occurred in
5% patients.13 In our study, 85% IPAA patients were
satisfied with the pouch and 44% patients had at least one
episode of pouchitis. Overall complications (early and
late) were encountered in 72% patients.
Conclusion
The study represent results from a developing country
with low prevalence of IBD and hence limited experience,
which may have contributed to relatively higher
morbidity and mortality. Objective functional outcome
assessment of IPAA is required. Lack of proper
documentation, retrieval of data and poor follow-up are
major setbacks in our setting.
Ethical Approval: As per institutional policy of AKUH,
retrospective reviews of files are exempted from ethical
review committee approval.
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